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Ankylosing spondylitis (AS)' and Reiter's syndrome (RS) are two major non-
rheumatoid arthritic diseases of unknown etiology . Because identical twins differ
in susceptibility to spondylitis (1), and because RS in particular is often preceded
by a discrete episode of infection (2), an infectious etiology has been suspected .
Microbes most prominently reported to be associated are Salmonella, Shigella,
Yersinia, and especially Klebsiella pneumoniae (3) . For example, the incidence of
Klebsiella is abnormally high in the bowel flora ofAS patients, and this coincides
with exacerbation of the disease (4). Moreover, patients with AS have elevated
titers of IgA antibodies against Klebsiella (5). Another marked feature of both
AS and RS is their correlation with the histocompatibility antigen HLA B27.
Whereas >90% of Caucasian AS and >80% of RS spondylitics are B27+, only
7% of healthy controls are this HLA type (6) . Consequently, HLA B27+ individ-
uals are at a high risk for contracting these diseases . But how HLA B27 is
involved in the pathogenesis of spondylitis is unknown. Possibly, genes located
within the major histocompatibility complex and linked to HLA B27 encode for
an immune response that results in susceptibility to the disease (7) . Alternatively,
HLA B27 antigen may itself participate directly in the tissue damaging process,
for example, by acting as a self antigen for a crossreacting immune response to
an invading microbe . This latter possibility could occur through molecular
mimicry.
Molecularmimicry is defined as the sharing ofepitopes from disparate proteins
(8). Although their origins may be as different as a microbe and a normal host
protein, the linear amino acid sequences or the conformational fits of two such
molecules may be homologous . An immune response, initiated by an invading
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microbe, i.e., bacterium, virus, or parasite, many then react not only with that
microbe, but also with the homologous host protein. Conceptually, molecular
mimicry can occur whenever the microbial and host determinants are sufficiently
similar toinduce a crossreactingimmune response, yet differentenough to break
immunologic self tolerance. Such crossreacting determinants have been shown
to be limited to as few as five amino acids (9).
To learn whether molecular mimicry occurs between the HLA B27 molecule
and microbes, and whether it is of significance to AS and RS, we searched for
homologies between the recently published sequence of HLA B27 (10, 11) and
entries of suspected bacterial pathogens listed in the Dayhoff protein sequence
data bank. Our strategy was to first synthesize such homologous peptides con-
taininghydrophilic shared sequencesand test theirability torecognize antibodies
from the sera of patients with AS and RS. Thereafter, we determined whether
such antibodies were unique for HLA B27+ patients with AS and RS, but absent
in healthy (nonarthritic) HLA 1327+ individuals. Here we report that HLA B27
shares six consecutive amino acids with Klebsiella pneumoniae nitrogenase, and
these are located in hydrophilic domains. Further, there is a highly significant
correlation between B27+ individuals that have either AS or RS, and production
of antibodies to the homologous area shared by HLA B27 and Klebsiella pneu-
moniae. In contrast, individuals with HLA B27 or other HLA haplotypes that
are free of AS or RS do not possess such auto- or antiklebsiella antibodies.
Materials and Methods
Computer Search.
￿
We used the Protein Sequence Database (Dayhoff Databank) (12),
containing 3,182 sequences with 694,014 residues in the release 5.0, and the database
search program (13). Overlapping segments of 10 amino acids from the HLA B27
sequence were compared with all sequences in the database. For scoring, we used the
Unitary Matrix, which assigns a value of 1 to residues that are identical and 0 to all the
others (14). The program was run in batch mode on a VAX/VMS system. (Digital
Equipment Corporation, Nashua, NH).
Hydrophobicity Plot.
￿
We used acomputer program toprogressivelyevaluate the hydro-
philicity and hydrophobicity of a protein along its sequence (15). Each amino acid was
assigned a hydrophobicity index, ranging from -1 for highest hydrophilicity to +1 for
highest hydrophobicity, according to the properties of their side chains. We plotted the
average ofthese indices over a stretch ofsix consecutive residues.
PeptideSynthesis.
￿
Selected peptides up to a length of 16 amino acids were synthesized
by the solid-phase method as described by Merrifield (16), using an automated peptide
synthesizer (430A; Applied Biosystems, Foster City, CA), cleaved from their insoluble
polystyreneresin beadswith hydrogen fluoride,extracted, and lyophilized. Peptides were
checked for purity by high-performance liquid chromatography using a Vydac TPC 18
column. All peptides had a purity ofat least 75%.
Patients.
￿
Patients were HLA typed as described (17) using standardized tissue typing
antisera. Patients were clinically verified asto having ASor RS. None ofthe patients had
undergone immunosuppressive therapy before the donation ofsera. Controls, non-AS or
RS patients, consisted of22 healthy, HLA B27+ individuals and 90 non-HLA-matched
individuals, of whom 20 were healthy young volunteers working in our laboratory and
70 were patients with diseases other than arthritis. All sera were stored in aliquots at
-20°C until tested.
Immunochemical Analysis.
￿
The presence and specificity ofantibodies toour synthesized
peptides were tested by ELISA. Flexible polyvinyl 96-well microtiter plates (Becton
Dickinson, Oxnard, CA) were incubated with 1 jug ofpeptide per well in PBS, and air
driedovernightat roomtemperature. Remainingbindingsites wereblocked byincubationSCHWIMMBECK ET AL.
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TABLE I
Comparison of the Amino Acid Sequences ofHLA Antigens and Klebsiella pneumoniae
Nitrogenase
Results
The homology between HLA 1327.1 and Klebsiella pneumoniae nitrogenase is shown in the box.
with ELISA diluent (10% heat-inactivated FCS, 0.2% Tween 20, 0.5 mM thimerosal in
PBS). An hour later the sera were added at twofold dilutions from 1 :10 to 1:320. After
an additional incubation of 1 .5 h at room temperature, the plates were washed five times
with PBS/0.2% Tween 20. Affinity-purified horseradish peroxidase-labelled goat anti-
human IgG + IgA + IgM in an appropriate dilution was added for 1 .5 h, and the plates
were washed again. The substrate solution (0 .4 mg/ml o-phenylenediamine, 0.01 % H202
in citrate buffer, pH 5.0) was added, and the reaction was stopped with 4 M H250, after
an incubation of 30 min in the dark. For evaluation the plates were read with an automated
ELISA scanner (Titertek Multiscan, Flow Laboratories), at 492 nm. Positive controls were
from the pooled sera of patients with RS. All samples were tested at least twice. Seropos-
itivity was defined as a value greater than the mean of 90 non-HLA-matched controls
plus two standard deviations. The statistical evaluation was done by using Student's t test.
Sequence Homology Between HLA B27 and Klebsiella pneumoniae.
￿
By computer
search, we noted several shared sequences of different lengths between HLA
1327 and microbes. The best homology consisted of six consecutive amino acids,
and occurred between HLA 1327 .1 residues 72-77 and Klebsiella pneumoniae
nitrogenase (18) residues 188-193. As Table I illustrates, the sharing of the
residues between Klebsiella and HLA 1327.1 is unique to this HLA haplotype
and the 1327 .1 subtype. Additional computer searches revealed no homologies
of six or more consecutive amino acids between HLA 1327.2 or 1327.3, or other
HLA-A or -B types with microbes. Thus these results indicate that amino acid
residues 72-77 of HLA 1327.1 lie in a hypervariable domain for HLA-B haplo-
types and yet show the strongest homology to Klebsiella, a microbe implicated
in HLA 1327-associated AS and RS.
Hydrophilicity Plots ofHLA B27 and Klebsiella.
￿
The hexamers shared by HLA
1327.1 and Klebsiella are both hydrophilic (Fig. 1). Thus, these sequences are
likely expressed on the molecule's outer surface and are thereby accessible to
the immune system. The homologous sequences are flanked in both residues by
less hydrophilic stretches.
Presence of Autoantibody to HLA B27 in Patients with AS.
￿
By ELISA, 7 of 24
Protein
Klebsiella pneumonia
nitrogenase
Residues
185-194
Amino acid sequence
N S R QTDREDE
HLA 1327.1 69-78 A K A T D R E D L
HLA 1327.2 69-78 A K A Q T D R E N L
HLA 1327.3 69-78 A K A Q T D R E S L
HLA B40 69-78 T N T Q T Y R E S L
HLA B7 69-78 AQAQTDRESL
HLA A2 69-78 A H S Q T H R V D L
HLA A3 69-78 A Q S Q T D R V D L
HLA A28 69-78 A Q S Q T D R V D L176
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FIGURE 1 . Hydrophobicity plot of HLA B27.1, residues
60-90 (top) and the Klebsiella pneumoniae nitrogenase, resi-
dues 175-205 (bottom) . These proteins share a homologous
sequence of six consecutive amino acids (dotted lines). Neg-
ative peaks indicate hydrophilic areas, whereas positive peaks
represent hydrophobic sequences.
FIGURE 2 . Antibodies in sera from indi-
viduals with HLA B27 bind to a synthetic
peptide representing residues 69-84 of
HLA B27.1 . The homologous residues to
the Klebsiella pneumoniae nitrogenase are
boxed . The open ci
from 24 individual patients with AS,
whereas the dots (*) show the values from
22 healthy individuals oftheHLAB27type.
The dilutions of the sera and the number
ofpositive sera are given on thex axis. The
background (shadowed areas) depicts the
mean value plus two standard deviations of
90 sera from nonarthritic and non-HLA-
matched controls .
sera (29%) from patients with AS contained antibodies that bound to a synthetic
ide representing the HLA B27.1 residues 69-84 and containing the homol-
ogous residues from Klebsiella . In contrast, none of the 22 sera fromHLA B27'
but healthy individuals tested the same way had similar antibodies (p < 0.01)
(Fig . 2) .
Presence of Autoantibodies to HLA B27 in Sera of Patients with RS.
￿
We also
tested the sera of 34 HLA B27+ patients with RS for antibodies that bound to a
synthetic peptide representing HLA B27 .1, residues 69-84. Of these 34 sera,
18 (53%) bound to the HLA B27 .1 peptide, whereas none of the 22 sera from
HLA B27' healthy individuals reacted (p< 0.01) (Fig . 3) . In addition, sera from
threeHLA B27- patientswho hadRS did nothave antibodies to theHLAB27.1
peptide (results not shown).
Presence of Antibodies to Klebsiella
RS .
￿
As shown in Table II >40% of the sera from patients with AS (24 sera
tested) and RS (34 sera tested) contained antibodies that bound to KlebsiellaSCHWIMMBECK ET AL .
TABLE II
Antibodies in Sera ofPatients with AS and RS Bind to Klebsiella pneumoniae Nitrogenase
Amino Acid Sequence 184-195 (CNSRQTDREDELI)
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FIGURE 3 . Antibodies in sera from indi-
viduals of the HLA B27 bind type to a
synthetic peptide representing amino acid
residues 69-84 ofHLA B27.1 .Amino acids
of HLA B27 homologous to the Klebsiella
pneumoniae nitrogenase are boxed . The
binding of 34 sera fromHLAB27' patients
with RS (0), and values for22 healthy HLA
B27' individuals. (0) are shown. The dilu-
tions of the sera and the proportion of pos-
itive sera are givenon the x axis . The back-
ground (shadowed area) represents themean
value plus two standard deviations of 90
sera from donors nothaving RS .
Data shown are numbers of positive sera over total studied per group . Positives consisted of values
greater than the mean plus two standard deviation of the 90 nonarthritis sera from non-HLA-typed
individuals .
pneumoniae nitrogenase amino acid residues 184-196. In contrast, only 1 of 90
sera from nonarthritic controls contained antibodies (p < 0.001) .
Discussion
The main finding ofour study is that a substantial proportion ofHLAB27.1'
patients with AS and RS have antibodies reactive with a peptide representing
residues 69-84 of the HLA B27 molecule . Further, the antibody is directed to
a hypervariable region ofHLA B27 that shares sequence homology with Klebsi-
ella pneumoniae nitrogenase, a microbial pathogen frequently associated with AS
andRS . These results suggest that an immune response directed initially during
infection with Klebsiella against that organism also reacts against HLA B27
sequences homologous with the Klebsiella region . This results in an immune
response against these host self determinants . Such a scenario would explain the
high incidence ofHLA B27 haplotype within AS and RS patient population, as
Serum
dilution With AS
HLA B27' individuals
With RS No arthritis
Non-HLA-typed
individuals with
no arthritis
1 :10 11/24 15/34 0/22 1/90
1 :20 9/24 14/34 0/22 1/90
1 :40 8/24 16/34 0/22 1/90
1 :80 8/24 15/34 0/22 1/90
1 :160 6/24 14/34 0/22 1/90178
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well as antibodies in the sera of these patients that crossreact with both HLA
B27 and Klebsiella.
The homology between Six consecutive amino acids of HLA B27.1 and
Klebsiellae pneumoniae nitrogenase is unlikely to occur bychance. The probability
that a hexamer would appear by chance in two different proteins is only 1 in
64,000,000, provided that amino acids occur at a random frequency. Indeed,
<1% of the possible sequences of six residues actually occur in the Dayhoff
collection of sequenced proteins (12).
There were other reasons for focusing on the shared sequence between HLA
B27.1 and Klebsiella . First, the homology noted is unique to the HLA B27.1
subtype, thus likely explaining why patients with AS/RS have the same HLA
type. Second,theKlebsiella pneumoniaenitrogenaseis a well-characterized protein
(18, 19) of a bacterium that has been shown to induce a crossreacting immune
response that specifically lyses B27+ lymphocytes from patients with spondylitis
(20-22). Third, recent experiments (D. H. Kono,J.-H. Chen, D. T. Y. Yu, P. A.
McLean, P. L. Schwimmbeck, and M. B. A. Oldstone, manuscript in preparation)
found that an mAb to HLA B27 crossreacted with the HLA B27.1 amino acid
sequences 69-84, and that rabbit antibodies to the predetermined amino acid
sequence of HLA.B27 .1 preferentially select HLA B27 isotypes and react with
the native proteins of HLA B27 and Klebsiella. By using shorter peptides, it was
shown that the antigenic determinant recognized by the patients' sera was
identical to the six-amino-acid sequence shared between HLA B27 and the
nitrogenase ofKlebsiella (results not shown).
Why do some AS and RS patients' fail to make antibodies against the HLA
B27 peptides? Our data relate only to homologies with Klebsiella, one of the
suspected etiologic agents. While part of the Klebsiella genome has been se-
quenced and its data deposited in the Dayhoff bank, the other suspected mi-
crobes, like Salmonella, Shigella, and Yersinia, have either not yet been com-
pletely sequenced or are not deposited in the data bank. Alternatively, the
inability to detect antibodies in some AS and RS patients may relate to stability
of the disease, poor immune responses, or low-affinity response. Nevertheless
our data define a subset within the AS/RS group andprovide apotential etiologic
agent and pathogenic mechanism for their disease.
Several factors can influence the capability ofan amino acid sequence shared
between two disimilar proteins to elicite a crossreactive immune response. Two
of the most critical events are the extent of the homology and the presence of
an antigenic determinant. Our recent studies indicate that an antigenic deter-
minant may consist ofonly four to five amino acids when conserved substitutions
occur at mismatched amino acid(s) (23). Further, a large number of homologous
amino acids between two proteins, in themselves, may not be sufficient to induce
an immunologic crossreactivity. For example, antibodies to two predetermined
peptides that differ in only 1 of 19 amino acids failed to show immune crossreac-
tivity (24), presumably because that one mismatch was a major change in the
binding site. Thus, changing one critical amino acid prevents the cross-reacting
immune response, despite extensive homology between two sequences. Other
examples ofthis are the single-amino-acid change in position 89 that discriminates
Thy-1 .1 from Thy-1.2 (25), and antibodies made against amino acid sequenceSCHWIMMBECK ET AL.
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63-84 of HLA B27.1 that discriminate among the other HLA B27 subtypes
(26), although there is only a single amino acid change at residue 77. A third
factor is the location of a shared sequence in the native protein. Epitopes
expressed on thesurface ofa protein are generally more accessible to the immune
system and thus better able to induce and be recognized by immune responses
than are hydrophobic sequences (27).
Molecular mimicry, or the sharing of similar sequences between two distinct
proteins, as from a microbe and self antigen, has been suspected of playing a
role in several diseases. For example, evidence of homology between cardiac
myosin and M protein of streptococci (29), A-gliadin and adenovirus found in
the gut (30), and the encephalitogenic site of myelin basic protein and several
viruses (9) have been hypothesized to generate crossreactive immune responses
that play a role in the pathogenesis ofrheumatic heart disease, ulcerative colitis,
and demyelating diseases, respectively. The experimental evidence for this con-
cept comes from studies showing that inoculation of a 10-amino-acid sequence
from a virus that shares a 6-amino-acid homology with the encephalitogenic site
ofmyelin basic protein generated an immune response against the native myelin
basic protein and caused a histopathologic picture of injury closely resembling
allergic encephalomyelitis (31). Accordingly, we suggest that infection with
Klebsiella may induce an autoimmune response directed againstthe homologous
epitope on HLA B27. Such an immune attack on HLA B27 antigens located on
cells from synovial membranes might cause the lesions associated with AS and
RS. Once begun, the autoimmune attack could be sustained by the release of
autoantigen from destroyed cells, even after clearance of the infecting microbe,
making it difficult to identify or recover the eliciting organism during the latter
stages of disease. Studies testing this hypothesis by analysis of autoimmune
response within thejoint space are currently underway.
Summary
Ankyiosing spondylitis (AS) and Reiter's syndrome (RS) both show a strong
correlation with the HLA B27 haplotype. We studied whether sharing of ho-
mologous amino acid sequences in the HLA B27 antigen with an invading
microbe might occur, and if so, what is the biological significance of such
homology. In a computer search ofthe Dayhoffdata bank, we found a homology
ofsix consecutive amino acids between HLA B27.1 antigen residues 72-77 and
Klebsiella pneumoniae nitrogenase residues 188-193. These shared sequences are
hydrophilic, suggesting locations on molecules exposed to the cell surface.
Immunochemical analysis showed that 18 of34 sera from patients with RS (53%)
and 7 of 24 sera from patients with AS (29%) contained antibodies that bound
to a synthesized peptide sequence representing residues 69-84 of HLA B27.1.
In contrast, only 1 of 22 sera from healthy, B27' controls (5%) contained
antibodies to this peptide (p < 0.01). Sera from three HLA B27- patients with
RS did not possess antibodies to the HLA B27 peptide. Additionally, >40% of
HLA B27 patients with AS or RS had antibodies to Klebsiella residues 184-193,
while none of the normal nonarthritic HLA B27 haplotype subjects did. Our
results suggest that an autoimmune response(s) directed against HLA B27.1 may
be a pathogenic mechanism in a subset ofpatients with AS and RS. Further, this180
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response may initially be induced against Klebsiella pneumoniae, a microorganism
that shares sequence homology with HLA B27.
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